Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Arcese

Showing results (111-120 of 160) with videos related to

Pageof 16
Sort By:
Leukemia|February 24, 2001
Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignanciesA Mengarelli, A P Iori, C Guglielmi, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Leukemia & Lymphoma|July 28, 2016
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMTM Michallet, B Corront, L Molina, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Blood|March 9, 2000
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)A Bacigalupo, B Bruno, P Saracco, et al.
Blood|September 1, 1995
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patientsH J Kolb, A Schattenberg, J M Goldman, et al.
British Journal of Haematology|June 1, 1997
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocolF Giona, L Annino, R Rondelli, et al.
Blood|May 26, 1999
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant GroupF Locatelli, V Rocha, C Chastang, et al.
Bone Marrow Transplantation|November 1, 1996
Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), ItalyC Uderzo, M G Valsecchi, A Balduzzi, et al.
Pageof 16

Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Leukemia|February 24, 2001
Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignanciesA Mengarelli, A P Iori, C Guglielmi, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Leukemia & Lymphoma|July 28, 2016
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMTM Michallet, B Corront, L Molina, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Blood|March 9, 2000
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)A Bacigalupo, B Bruno, P Saracco, et al.
Blood|September 1, 1995
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patientsH J Kolb, A Schattenberg, J M Goldman, et al.
British Journal of Haematology|June 1, 1997
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocolF Giona, L Annino, R Rondelli, et al.
Blood|May 26, 1999
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant GroupF Locatelli, V Rocha, C Chastang, et al.
Bone Marrow Transplantation|November 1, 1996
Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), ItalyC Uderzo, M G Valsecchi, A Balduzzi, et al.
Pageof 16